#tumorvisualization search results
Our new #surgicalplanning application offers more than just #tumorvisualization. Come meet us at poster P4-02-24 during session 4 at #sabcs22 to learn more. #sabcs22 #surgicaloncology #precisionmedicine
Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309. Read the full media release: bit.ly/3M4rLUI #innovation #tumorvisualization
We’ve been awarded a Small Business #Innovation Research grant from @NIH. This will support our study of targeted fluorescent imaging agent to improve #tumorvisualization. Read the announcement: bit.ly/3OHWEzL
Phase 2 data published in @STS_CTsurgery journal @annalsthorsurg show VGT-309 may help surgeons see difficult-to-find and previously undetected tumors in real-time during #MIS and robotic-assisted surgery. bit.ly/4bNYCIE #TumorVisualization #LungCancer
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer. #tumorvisualization #lungcancer vergentbio.com/news-2022-nov2…
vergentbio.com
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development...
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development...
At @WMISWMIC next week, @PennMedicine’s Dr. Sunil Singhal will share clinical research that shows how enhanced tumor visualization may benefit surgeons and patients during #lungcancer surgery. Learn more here: bit.ly/4e1KZHw #WMIC2024 #tumorvisualization #meded #MedX
Phase 2 data published in @STS_CTsurgery journal @annalsthorsurg show VGT-309 may help surgeons see difficult-to-find and previously undetected tumors in real-time during #MIS and robotic-assisted surgery. bit.ly/4bNYCIE #TumorVisualization #LungCancer
Our new #surgicalplanning application offers more than just #tumorvisualization. Come meet us at poster P4-02-24 during session 4 at #sabcs22 to learn more. #sabcs22 #surgicaloncology #precisionmedicine
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer. #tumorvisualization #lungcancer vergentbio.com/news-2022-nov2…
vergentbio.com
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development...
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development...
We’ve been awarded a Small Business #Innovation Research grant from @NIH. This will support our study of targeted fluorescent imaging agent to improve #tumorvisualization. Read the announcement: bit.ly/3OHWEzL
Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309. Read the full media release: bit.ly/3M4rLUI #innovation #tumorvisualization
Our new #surgicalplanning application offers more than just #tumorvisualization. Come meet us at poster P4-02-24 during session 4 at #sabcs22 to learn more. #sabcs22 #surgicaloncology #precisionmedicine
Something went wrong.
Something went wrong.
United States Trends
- 1. Blue Origin 7,413 posts
- 2. Megyn Kelly 29.8K posts
- 3. New Glenn 8,416 posts
- 4. Vine 33.1K posts
- 5. Senator Fetterman 17.9K posts
- 6. CarPlay 4,314 posts
- 7. #NXXT_JPMorgan N/A
- 8. Brainiac 4,974 posts
- 9. Portugal 62.6K posts
- 10. World Cup 99K posts
- 11. Matt Gaetz 13.5K posts
- 12. Padres 29.7K posts
- 13. GeForce Season 1,035 posts
- 14. Eric Swalwell 25.1K posts
- 15. Black Mirror 5,147 posts
- 16. Katie Couric 9,601 posts
- 17. Osimhen 99.6K posts
- 18. Man of Tomorrow 5,621 posts
- 19. Cynthia 111K posts
- 20. Apple TV 8,367 posts